Organon & Co. (OGN)
13.42
0.00 (0.00%)
USD |
NYSE |
May 19, 16:00
13.43
+0.01
(+0.07%)
Pre-Market: 20:00
Organon Cash from Investing (Quarterly) : 386.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -10.21B |
| Eli Lilly & Co. | -3.916B |
| Ligand Pharmaceuticals, Inc. | -94.35M |
| Veradermics, Inc. | -101.30M |
| Johnson & Johnson | -1.04B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 225.00M |
| Cash from Financing (Quarterly) | -38.00M |
| Free Cash Flow | 708.00M |
| Free Cash Flow Per Share (Quarterly) | 0.6771 |
| Free Cash Flow to Equity (Quarterly) | 409.00M |
| Free Cash Flow to Firm (Quarterly) | 255.46M |
| Free Cash Flow Yield | 20.22% |